Apha Complete Review for Pharmacy

Description

The NAPLEX® (North American Pharmacist Licensure Examination®) is the standard licensing exam that all U.S. pharmacy students must pass to practice pharmacy. The 9th edition of The APhA Complete Review for Pharmacy, written by more than 40 chapter authors, provides a thorough review of the topics covered on the NAPLEX®. New to this edition are three chapters – Drug Information, Biostatistics, and Clinical Trial Design. An updated chapter on new drug approvals, indications, and formulations is also included.

Key Features:

• Top 200 drugs—Begin your NAPLEX® preparation by learning the generic and trade names for the top 200 drugs.
• Math—After generic and trade names, this is the most important single area to review.
• Drug therapy for chronic and common diseases—This is the heart of today’s NAPLEX and the subject of more than half of the 40 chapters in this study guide.
• Summary tables of the major drug categories—Drug charts, including dosage schedules and dosage forms, are provided in each of the therapeutic chapters.
• New to this edition are three new chapters—Drug Information, Biostatistics, and Clinical Trial Design. An updated chapter on new drug approvals, indications, and formulations is also included.
• Review questions— All chapters end with 20 or more practice exam questions and answers as well as explanation that reinforce key learning points.
• Available online through subscription to PharmacyLibrary (www.pharmacylibrary.com). On PharmacyLibrary, an interactive exam center allows users to create a custom practice exam from 45 different disease state categories, using a bank of over 1,600 questions, and student users can email their results from an exam directly to faculty.

Table of Contents:

• Pharmacy Math
• Federal Pharmacy Law
• Dosage Forms and Drug Delivery Systems
• Compounding
• Sterile Products
• Pharmacokinetics, Drug Metabolism, and Drug Disposition
• Biotechnology and Pharmacogenomics
• Biostatistics
• Drug Information
• Clinical Trial Design
• Hypertension
• Heart Failure
• Cardiac Arrhythmias
• Ischemic Heart Disease
• Hyperlipidemia
• Diabetes Mellitus
• Thyroid, Adrenal, and Miscellaneous Endocrine Drugs
• Women’s Health
• Kidney Disease
• Critical Care, Fluids, and Electrolytes
• Nutrition
• Oncology
• Solid Organ Transplantation
• Gastrointestinal Diseases
• Rheumatoid Arthritis, Osteoarthritis, Gout, and Lupus
• Pain Management and Migraines
• Seizure Disorders
• Psychiatric Disease
• Common Dermatologic Disorders
• Nonprescription Medications
• Asthma and Chronic Obstructive Pulmonary Disease
• Infectious Disease
• Anti-Infective Agents
• Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome
• Immunization
• Pediatrics
• Geriatrics and Gerontology
• Toxicology and Chem-Bioterrorism
• Anemias
• Venous Thromboembolic Disease
• 2009–2011 Drug and Data Updates
• Appendices